advertisement
Abstract #90221 Published in IGR 21-3
Generics versus brand-named drugs for glaucoma: the debate continues
Bhartiya S; Dhingra D; Dhingra D; Dhingra DRomanian journal of ophthalmology 2020; 64: 239-244
There are three options for a given class of drugs, including brand name drugs, generic and branded generic drugs. Brand name drugs are costlier as compared to generic and branded generic drugs because they are innovator molecules developed by a company after many years of research and come into the market with a patent, whereas branded generic drugs are produced by a different company once the patent of innovator company expires. Given that glaucoma is a chronic, largely asymptomatic disease, the choice of drugs is extremely important: the duration of medication is often lifelong, and the cost of drugs, side effects and efficacy affect compliance and adherence to therapy. This review is a brief overview of the available brand name and branded generic drugs for the management of glaucoma, in terms of efficacy and side effect profiles. It also aimed to guide rational and pragmatic drug choices in different clinical scenarios.
Glaucoma Services, Fortis Memorial Research Institute, Gurugram, Haryana, India.
Classification:
15 Miscellaneous
11.20 Other (Part of: 11 Medical treatment)
